Skip to main content

Table 4 The clinical features of biopsied oral-facial malignancies in different countries in the Middle East

From: Oro-facial malignancy in north of Iraq: a retrospective study of biopsied cases

 

Country

Author(s)

Year

M:F

Prevalence

Age$

Most affected oral site

Oral malignancies

Iraq

Al–Niaimi [20]

2006

1.2:1

2%

58.3

Lip 41.1%, tongue 23.5%

Khudier [19]

2012

0.9:1

12.3%

Hassawi et al. [21]

2010

12.8%*

Mohammed [22]

2014

1.56:1

0.12%

39.1

Perioral 39.5%, buccal mucosa 18.6%

Museedi and Younis [16]

2014

1.37:1

2%

 > 60

Tongue > lip

Aljazaeri et al. [23]

2020

1.38:1

19.1%

 > 69

Tongue 46.7%

UAE

Anis and Gaballah [8]

2013

14.9%

Yemen

Halboub et al. [9]

2011

1:1

4%

58.4

Tongue 29.9%, floor 10.2%

Sudan

Osman et al. [10]

2010

3:2

50%

 > 50

Overlap 38.7%, tongue 9.2%

Saudi Arabia

Ali et al. [12]

2013

1.42:1

9.9%

45.4

 

Saleh et al. [11]

2017

0.6:1

38.8%

64.8

Tongue 43.7%, buccal mucosa 26.4%

AlHindi et al. [13]

2019

1.26:1

5.7%

49.52

Kuwait

Ali and Sundaram [6]

2012

55.6%

Joseph et al. [7]

2019

1.4:1

3.6%

51.29

Jordan

Telfah and Hammouri [14]

2014

1.6:1

1.5%

OSCC

Iraq

Al–Niaimi [20]

2006

1.2:1

80%

Lip 51.5%,tongue 29.4%

Khudier [19]

2012

1.2:1

56.1%

50–70

Lip 50%, tongue20%

Hassawi et al. [21]

2010

3:1

58.9%

Mohammed [22]

2014

49%

Museedi and Younis [16]

2014

91%

Aljazaeri et al. [23]

2020

1.36:1

84.1%

UAE

Anis and Gaballah [8]

2013

4.13:1

77%

54.9

Tongue 51.9%, buccal mucosa 19.48%

Yemen

Halboub et al. [9]

2011

93.2%

Sudan

Osman et al. [10]

2010

73.6%

 > 50

Saudi Arabia

Ali et al. [12]

2013

1.37:1

18.2%

60.39

Saleh et al. [11]

2017

0.54:1

93.1%

65.1

Tongue 43.7%, buccal mucosa 26.4%

AlHindi et al. [13]

2019

1.4:1

65.7%

56.6

Kuwait

Ali and Sundaram [6]

2012

1:1

44.4%

53.9

Buccal mucosa 39%, tongue28.5%

Joseph et al. [7]

2019

64%

Jordan

Telfah and Hammouri [14]

2014

67.3%

Lip 23.7%, tongue 18.6%

  1. $Mean of age, – not mentioned